Cytonus Therapeutics Expands C-suite as it Transitions to a Clinical Stage Company

SAN DIEGO--(BUSINESS WIRE)--Cytonus Therapeutics, Inc., a biotherapeutic company developing transformative medicines based on next generation drug-delivery platform technology called Cargocytes™, announced today that Mickey Kim, M.D., M.B.A. has joined the company as Chief Business Officer. In addition, Cytonus has added Sherry M. Carty, Ph.D., as Director of Intellectual Property and Karen Markham has been promoted to Chief Administrative Officer. Dr. Kim brings significant corporate developme